ICT Ep16: Revolutionizing Cancer Trial Enrollment with Selin Kurnaz (Part 1 of 3)

In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford are joined by Selin Kurnaz, CEO and founder of Massive Bio, an AI-driven platform designed to connect cancer patients with clinical trials. Our conversation dives deep into the challenges of patient awareness, access, and logistical hurdles in trial enrollment. Selin shares how her personal experience with her uncle’s cancer diagnosis led to the creation of Massive Bio and her mission to streamline trial enrollment using technology. We discuss the "Last Mile" problem and walk through how combining technological scale with personalized concierge services can help patients not only find relevant trials but also overcome the logistical and financial barriers that can prevent participation. With insights into the complexities of the clinical trial landscape, the discussion highlights the critical steps needed to bridge the gap between patients and life-saving treatments.